SANUWAVE Health, Inc.

SANUWAVE Health, Inc.

NNASDAQ:SNWV
1.81
USD
-0.01
(-0.55%)
0.31EPS
15.74P/E
40.52MMarket Cap
Mar 19Next Earn

Total Valuation

USD

As of September 30, 2026, SANUWAVE Health, Inc. carries a market capitalization of 40.52M, placing it among publicly traded companies globally. Its enterprise value stands at 53.55M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap40.52M
Enterprise Value53.55M

Important Dates

SANUWAVE Health, Inc.'s next confirmed earnings release is scheduled for March 19, 2027.

Earnings Date3/19/2027

Share Statistics

As of September 30, 2026, SANUWAVE Health, Inc. has 8.60M shares outstanding.

Shares Outstanding8.60M

Valuation Ratios

As of September 30, 2026, SANUWAVE Health, Inc. trades at a trailing price-to-earnings ratio of 15.74. The price-to-sales ratio is 0.99, and the price-to-book ratio stands at 14.22.

PE Ratio15.74
PS Ratio0.99
PB Ratio14.22
P/TBV Ratio-5.70
P/FCF Ratio16.50
P/OCF Ratio12.31

Enterprise Valuation

These figures are as of September 30, 2026. The EV/Sales ratio of 1.31 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. SANUWAVE Health, Inc. trades at an EV/FCF ratio of 11.99, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 53.55M versus a market cap of 40.52M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales1.31
EV / FCF11.99

Financial Position

As of September 30, 2026, SANUWAVE Health, Inc. maintains a current ratio of 1.18, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 687.96, indicating elevated leverage, while an interest coverage ratio of -0.12 demonstrates limited ability to service its debt obligations.

Current Ratio1.18
Quick Ratio0.70
Debt / Equity687.96
Debt / EBITDA-74.27
Interest Coverage-0.12

Financial Efficiency

USD

These figures cover the twelve months ended September 30, 2026. Return on invested capital (ROIC) is negative at -8.43, so the business is destroying capital rather than earning a return above its cost of capital. Return on assets (ROA) stands at 7.55, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 21.17, useful for judging operating efficiency across full business cycles. The company generates approximately 746,018.18 in revenue per employee across its workforce of 55.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.45 indicates how many times SANUWAVE Health, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)7.55
Return on Invested Capital (ROIC)-8.43
Return on Capital Employed (ROCE)21.17
Revenue Per Employee746,018.18
Employee Count55.00
Inventory Turnover1.45

Taxes

USD

Over the twelve months ended September 30, 2026, SANUWAVE Health, Inc. recorded 69,000.00 in income tax expense. That works out to an effective tax rate of 2.53, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 2.73M, leaving 2.57M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax69,000.00
Effective Tax Rate2.53

Stock Price Statistics

USD

As of the close on November 16, 2026, SANUWAVE Health, Inc.'s stock has declined approximately 94.51% over the past 52 weeks. The 50-day moving average sits at 4.46, while the 200-day moving average is 12.17.

52-Week Price Change-94.51%
50-Day Moving Average4.46
200-Day Moving Average12.17

Income Statement

USD

Over the twelve months ended September 30, 2026, SANUWAVE Health, Inc. generated 41.03M in revenue and converted that into 2.57M in net income, yielding earnings per share of 0.31. EBITDA reached -264,000.00, while operating income came in at -1.86M.

Revenue41.03M
Gross Profit31.19M
Operating Income-1.86M
Pretax Income2.73M
Net Income2.57M
EBITDA-264,000.00
EBIT-1.86M
Earnings Per Share (EPS)0.31

Balance Sheet

USD

As of September 30, 2026, SANUWAVE Health, Inc. holds 6.57M in cash and equivalents against 19.61M in total debt, resulting in a net debt position of 11.59M. Total book value stands at 2.85M, with working capital of 2.91M providing operational flexibility.

Cash & Cash Equivalents6.57M
Total Debt19.61M
Net Debt11.59M
Equity (Book Value)2.85M
Book Value Per Share0.33
Working Capital2.91M

Cash Flow

USD

SANUWAVE Health, Inc. produced 3.29M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -907,000.00 in capital expenditures, free cash flow totaled 2.38M - equivalent to 0.28 per share.

Operating Cash Flow3.29M
Capital Expenditures-907,000.00
Free Cash Flow2.38M
FCF Per Share0.28

Margins

Over the twelve months ended September 30, 2026, SANUWAVE Health, Inc. posted a gross margin of 76.01, reflecting its pricing power and cost economics. The operating margin of -4.54 and net profit margin of 6.27 provide insight into operational efficiency.

Gross Margin76.01
Operating Margin-4.54
Pretax Margin6.65
Profit Margin6.27
EBITDA Margin-0.64

Dividends & Yields

These figures cover the twelve months ended September 30, 2026. Free cash flow yield stands at 6.06, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 14.29, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to SANUWAVE Health, Inc. shareholders.

Shareholder Yield14.29
FCF Yield6.06

Stock Splits

SANUWAVE Health, Inc.'s most recent stock split took place on October 18, 2024 with a 375:1 split ratio.

Last Split Date10/18/2024
Split Ratio375:1

Scores

As of September 30, 2026, SANUWAVE Health, Inc. has an Altman Z-Score of -12.76, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-12.76